Cite
HARVARD Citation
Jeffery, H. et al. (n.d.). Low‐dose interleukin‐2 promotes STAT‐5 phosphorylation, Treg survival and CTLA‐4‐dependent function in autoimmune liver diseases. Clinical and experimental immunology. pp. 394-411. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jeffery, H. et al. (n.d.). Low‐dose interleukin‐2 promotes STAT‐5 phosphorylation, Treg survival and CTLA‐4‐dependent function in autoimmune liver diseases. Clinical and experimental immunology. pp. 394-411. [Online].